Welcome to our dedicated page for MetLife news (Ticker: MET), a resource for investors and traders seeking the latest updates and insights on MetLife stock.
MetLife, Inc. (NYSE: MET) news hub provides investors and financial professionals with centralized access to official corporate communications and market-moving developments. This resource aggregates essential updates from one of the world's largest life insurance providers, spanning 50 countries with $687 billion in total assets under management.
Track critical announcements including quarterly earnings releases, regulatory filings, and strategic partnership updates. Our curated feed includes product launches, leadership changes, and dividend declarations relevant to MET's operations in insurance, retirement solutions, and employee benefits. Bookmark this page for real-time access to SEC filings, investor presentations, and analyst commentary.
Key coverage areas include MET's group benefits innovations, international market expansions, and risk management initiatives. Stay informed about developments across MetLife's core segments: U.S. group insurance, global retirement products, and asset management strategies. Verify timestamps on all materials and cross-reference original source links for due diligence purposes.
MetLife (NYSE: MET) has issued a warning to shareholders regarding an unsolicited mini-tender offer from Potemkin Limited. The offer seeks to purchase up to 10,000 shares (approximately 0.00002%) of MetLife's common stock at $53.00 per share, which is 34.42% below the current market price of $80.82 as of September 12, 2025.
MetLife strongly recommends shareholders reject this offer and exercise caution, highlighting that mini-tender offers avoid many SEC disclosure requirements by targeting less than 5% of shares outstanding. The offer is set to expire on October 7, 2025, and shareholders who have already tendered their shares can withdraw them before the deadline.
MetLife (NYSE:MET) has announced the launch of a new Cancer Support benefit through a strategic partnership with Private Health Management. The benefit, available from January 1, 2026, will enhance MetLife's Critical Illness Insurance offering by providing personalized cancer care navigation and financial support.
The service comes as cancer diagnoses are expected to exceed 2 million cases in 2025. Through Private Health Management's expertise, the program has demonstrated significant outcomes, including a 20% reduction in average cost per case, 15% reduction in unnecessary treatments, and 70% modification of treatment plans for optimal care.
MetLife (NYSE: MET) has announced the complete redemption of its Series G Preferred Stock, scheduled for September 15, 2025. The redemption will be executed at $1,000 per share, which represents the liquidation preference value. Shareholders will receive a final regular dividend of $19.250 per share, paid separately to holders of record as of August 29, 2025.
The redemption will be processed through The Depository Trust Company (DTC), with Computershare Trust Company, N.A. serving as the redemption agent. After the redemption date, all dividends on the Series G Preferred Stock will cease to accrue.
MetLife Investment Management (MIM), the institutional asset management arm of MetLife Inc. (NYSE: MET), has appointed Geert Henckens as global head of Private Fixed Income. Henckens, who previously served as global head of Investment Grade Private Credit since 2023, succeeds Brian Funk, who became MIM's president in June 2025.
The appointment comes as MIM continues to strengthen its private fixed income platform, which originated $21.6 billion in private fixed income transactions in 2024. As of June 30, 2025, MIM manages $154.8 billion in private fixed income assets and has total assets under management of $624.3 billion. Henckens will lead teams focused on originating and managing private asset investments, including corporate and infrastructure debt, private asset-based finance, and middle market direct lending.
MetLife (NYSE: MET) announced that CEO Michel Khalaf and CFO John McCallion will participate in a fireside chat at the 2025 Keefe, Bruyette & Woods Annual Insurance Conference on September 3, 2025, from 10:05 a.m. to 10:45 a.m. ET.
The presentation will be accessible via live audio webcast, with replay available until September 10, 2025. Interested parties should access the website 15 minutes before the presentation to install necessary software.
MetLife (NYSE: MET) has announced the release of a second quarter 2025 financial update video featuring John McCallion, the company's executive vice president, chief financial officer, and head of MetLife Investment Management. The video update is available for viewing on MetLife's corporate website.
As one of the world's leading financial services companies, MetLife operates in over 40 global markets, providing insurance, annuities, employee benefits, and asset management services. The company, founded in 1868, maintains strong market positions in the United States, Asia, Latin America, Europe, and the Middle East.
MetLife (NYSE: MET) reported Q2 2025 financial results with mixed performance across segments. Net income declined 23% to $698 million ($1.03 per share), while adjusted earnings fell 16% to $1.4 billion ($2.02 per share). The company saw premiums, fees and other revenues of $12.7 billion, with adjusted PFOs excluding pension risk transfers up 5% to $12.4 billion.
Notable segment performance included Group Benefits adjusted earnings down 25%, RIS adjusted earnings declining 10%, and EMEA showing strong growth with adjusted earnings up 30%. The company maintained strong capital position with $5.2 billion in holding company cash and returned approximately $900 million to shareholders through dividends and share repurchases.
Net investment income rose 9% to $5.7 billion, though variable investment income decreased to $195 million due to lower private equity returns. Book value per share increased 7% to $35.79, while adjusted book value per share grew 6% to $56.23.
MetLife (NYSE: MET) has appointed Adrienne O'Neill as Executive Vice President and Chief Accounting Officer, effective September 2, 2025. O'Neill will report to John McCallion, Executive Vice President and Chief Financial Officer, and head of MetLife Investment Management.
O'Neill brings 18 years of experience from Manulife Financial Corporation, where she held key positions including CFO for Asia, Global Controller and Group Chief Accounting Officer, and Global Head of Investor Relations. She will lead corporate accounting, reporting activities, and financial planning and analysis at MetLife. She replaces interim Chief Accounting Officer Toby Srihiran Brown, who will continue as Executive Vice President and Global Head of Reinsurance.
MetLife (NYSE: MET) has scheduled its second quarter 2025 earnings conference call and audio webcast for Thursday, August 7, 2025, from 9-10 a.m. (ET). The company will release its Q2 2025 earnings report and Financial Supplement on Wednesday, August 6, 2025, after market close.
The conference call will be accessible via live webcast, with replay options available through telephone and internet until August 14, 2025. For telephone replay access, participants can dial 800-770-2030 (U.S.) or 647-362-9199 (international) using Conference ID 82058.
MetLife (NYSE: MET) has announced its third quarter 2025 common stock dividend of $0.5675 per share. The dividend will be paid on September 9, 2025, to shareholders of record as of August 5, 2025.
MetLife, established in 1868, operates in over 40 global markets and is a leading financial services provider offering insurance, annuities, employee benefits, and asset management services. The company maintains strong market positions in the United States, Asia, Latin America, Europe, and the Middle East.